| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $22,578,025 | 38 | 100 |
| Bhanji Muna | director | 0 | $0 | 2 | $161,553 | $-161,553 |
| EPSTEIN ROBERT S | director | 0 | $0 | 1 | $440,129 | $-440,129 |
| Febbo Phillip G. | Chief Scientific & Med Officer | 0 | $0 | 2 | $1.05M | $-1.05M |
| Leite John | Chief Commercial Officer-CLIA | 0 | $0 | 5 | $1.25M | $-1.25M |
| Holstein Jens | director | 0 | $0 | 4 | $1.36M | $-1.36M |
| Wygant Jonathan | VP, Chief Accounting Officer | 0 | $0 | 3 | $1.54M | $-1.54M |
| McGuire Annie | SVP, General Counsel | 0 | $0 | 7 | $1.72M | $-1.72M |
| Chambers Rebecca | Chief Financial Officer | 0 | $0 | 5 | $1.91M | $-1.91M |
| JONES EVAN/ FA | director | 0 | $0 | 2 | $2M | $-2M |
| EASTHAM KARIN | director | 0 | $0 | 4 | $2.24M | $-2.24M |
| Stapley Marc | Chief Executive Officer | 0 | $0 | 3 | $8.92M | $-8.92M |
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its …
Over the last 12 months, insiders at Veracyte, Inc. have bought $0 and sold $22.58M worth of Veracyte, Inc. stock.
On average, over the past 5 years, insiders at Veracyte, Inc. have bought $980,094 and sold $9.35M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 60,000 shares for transaction amount of $980,094 was made by Stapley Marc (Chief Executive Officer) on 2022‑06‑10.
| 2026-10-27 | Sale | Holstein Jens | director | 7,500 0.0093% | $50.00 | $375,000 | +0.02% | |
| 2026-10-27 | Sale | EASTHAM KARIN | director | 14,850 0.0184% | $50.00 | $742,573 | +0.02% | |
| 2026-10-19 | Sale | Bhanji Muna | director | 1,864 0.0023% | $43.70 | $81,457 | +11.87% | |
| 2026-09-24 | Sale | Holstein Jens | director | 7,500 0.0091% | $47.00 | $352,500 | -6.02% | |
| 2026-09-21 | Sale | Leite John | Global Chief Commercial Off | 4,015 0.0051% | $40.00 | $160,600 | +9.42% | |
| 2026-09-14 | Sale | Holstein Jens | director | 5,000 0.0062% | $40.95 | $204,747 | +9.22% | |
| 2026-09-04 | Sale | Chambers Rebecca | Chief Financial Officer | 3,652 0.0046% | $43.10 | $157,394 | +4.37% | |
| 2026-09-04 | Sale | Febbo Phillip G. | Chief Scientific & Med Officer | 13,110 0.0166% | $43.05 | $564,410 | +4.37% | |
| 2026-09-04 | Sale | McGuire Annie | EVP, General Counsel | 3,254 0.0041% | $43.09 | $140,212 | +4.37% | |
| 2026-09-01 | Sale | Bhanji Muna | director | 1,864 0.0023% | $42.97 | $80,096 | +2.51% | |
| 2026-06-18 | Sale | EASTHAM KARIN | director | 3,729 0.0046% | $52.89 | $197,234 | -14.15% | |
| 2026-06-04 | Sale | Stapley Marc | Chief Executive Officer | 138,051 0.1781% | $50.12 | $6.92M | -7.35% | |
| 2026-06-04 | Sale | Chambers Rebecca | Chief Financial Officer | 3,561 0.0046% | $49.73 | $177,083 | -7.35% | |
| 2026-06-04 | Sale | McGuire Annie | EVP, General Counsel | 3,176 0.0041% | $49.76 | $158,036 | -7.35% | |
| 2026-06-04 | Sale | Leite John | Global Chief Commercial Off | 13,975 0.018% | $50.07 | $699,732 | -7.35% | |
| 2026-05-22 | Sale | Wygant Jonathan | VP, Chief Accounting Officer | 24,000 0.0303% | $45.40 | $1.09M | +2.91% | |
| 2026-05-20 | Sale | EPSTEIN ROBERT S | director | 10,000 0.0122% | $44.01 | $440,129 | +2.50% | |
| 2026-05-06 | Sale | McGuire Annie | SVP, General Counsel | 10,204 0.0121% | $39.02 | $398,211 | +11.87% | |
| 2026-03-04 | Sale | Stapley Marc | Chief Executive Officer | 45,523 0.0571% | $35.97 | $1.64M | +21.42% | |
| 2026-03-04 | Sale | Chambers Rebecca | Chief Financial Officer | 18,341 0.0231% | $36.14 | $662,869 | +21.42% |
| Stapley Marc | Chief Executive Officer | 440494 0.5479% | $22.15M | 1 | 6 | +45.22% |
| Holstein Jens | director | 27471 0.0342% | $1.38M | 1 | 7 | +12.01% |
| Anderson Bonnie H | director | 42681 0.0531% | $2.15M | 4 | 51 | +38.63% |
| Brooks Julie | EVP,General Counsel, Secretary | 3122 0.0039% | $157,005.38 | 4 | 0 | <0.0001% |
| Increased Positions | 177 | +53.31% | 7M | +7.74% |
| Decreased Positions | 144 | -43.37% | 10M | -10.84% |
| New Positions | 64 | New | 3M | New |
| Sold Out Positions | 29 | Sold Out | 618,988 | Sold Out |
| Total Postitions | 365 | +9.94% | 87M | -3.1% |
| Blackrock, Inc. | $553,279.00 | 16.52% | 13.05M | +5M | +68.88% | 2025-09-30 |
| Vanguard Group Inc | $360,488.00 | 10.77% | 8.5M | +403,737 | +4.98% | 2025-09-30 |
| Artisan Partners Limited Partnership | $312,434.00 | 9.33% | 7.37M | +1M | +16.59% | 2025-09-30 |
| Fmr Llc | $288,070.00 | 8.6% | 6.8M | -1M | -16.18% | 2025-09-30 |
| Ark Investment Management Llc | $189,304.00 | 5.65% | 4.47M | +665,686 | +17.52% | 2025-09-30 |
| State Street Corp | $178,024.00 | 5.32% | 4.2M | +1M | +32.49% | 2025-09-30 |
| Wellington Management Group Llp | $142,991.00 | 4.27% | 3.37M | -100,548 | -2.89% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $132,179.00 | 3.95% | 3.12M | +95,664 | +3.17% | 2025-09-30 |
| Arrowmark Colorado Holdings Llc | $107,914.00 | 3.22% | 2.55M | -33,084 | -1.28% | 2025-09-30 |
| Geode Capital Management, Llc | $80,179.00 | 2.39% | 1.89M | -39,947 | -2.07% | 2025-09-30 |